Novartis to spin off generics business Sandoz next year
The company started a strategic review of Sandoz last October - examining a range of options, including retaining the business,…
Author
Thai king’s medical firm reports record profit after vaccine deal with AstraZeneca
The company is part of King Maha Vajiralongkorn's vast fortune, which includes land and property estimated at between $30 billion…
British scientists behind key COVID trial launch study to test monkeypox treatment
Although there are vaccines developed for the closely related smallpox that can reduce the risk of catching monkeypox, there are…
Pfizer-BioNTech COVID shot 73.2 per cent effective in kids aged under five years, reveals new data
The updated data released yesterday showed 13 children had COVID-19, at least seven days after receiving a third dose of the…
Moderna to supply 12 million doses of Omicron-targetted COVID shot to Canada
The Canadian government had entered into a supply deal with the company last year for supply of its COVID vaccine for 2022 and…
Canada OKs Pfizer COVID booster for kids aged five-11 years
The authorisation for a booster shot was granted after a thorough, independent review of the vaccine, which "provides good…
US FDA orders Pfizer to test second Paxlovid course for rebound COVID patients
The drugmaker must produce initial results of a randomised controlled trial of a second course of the antiviral by 30th September…
WHO recommends use of two antibody drugs against Ebola
The drugs - Regeneron's Inmazeb and Ridgeback Bio's Ebanga- use laboratory-made monoclonal antibodies that mimic natural…
Novartis fails again to reuse anti-inflammatory drug to treat lung cancer
The failure in the latest trial, called Canopy A, is a setback for Novartis after canakinumab failed in two separate studies last…
UK first to approve Omicron COVID shot with Moderna nod
The UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by Moderna as a booster for adults